生物テロ防御のアメリカ市場見通し2022

RNCOSが発行した調査報告書(DATA1122067)
◆英語タイトル:US Biodefense Market Outlook 2022
◆商品コード:DATA1122067
◆発行会社(リサーチ会社):RNCOS
◆発行日:2016年11月
◆ページ数:45
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:防衛
◆販売価格オプション(消費税別)
Single UserUSD1,000 ⇒換算¥113,000見積依頼/購入/質問フォーム
Multi UserUSD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はRNCOS社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。RNCOS社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

The dangers posed by the weapons of mass destruction have caught the attention of every nation worldwide. These weapons can be characterized by their potential for large-scale destruction and the indiscriminate nature of their effects, notably against civilians. Increasing threat of biological, chemical as well as nuclear terrorism and disease outbreaks; along with growing R&D investments in the field of biotechnology is expected to drive biodefense market growth with a CAGR of 9% during the forecasted period of 2017-2022.
The report “US Biodefense Market Outlook 2022” unfolds the market scenario of the US BioDefense market. The report provides an overview of the Biodefense market with respect to biological defense. It further gives a detailed analysis of its sub-segment, with an in-depth study of the Biodefense market scenario prevalent in the country.

A detailed analysis was carried out in the research to understand the significance of the biodefense market in United States, which revealed that Anthrax is the biggest bioterrorism threat to the country, as it is highly infectious and communicable. The other major threats are Small Pox and Botulism. Further, a meticulous category-wise segmentation has provided the understanding of the biodefense-related demand parameters prevailing in the country.

The latter half of the report provides the status of the current rules and regulations that govern the Biodefense market. It also focuses on the analysis of current drivers, and the challenges of the market. The report further highlights the competitive landscape of the US BioDefense market, describing the business of the major industry players. On the whole, the report provides all the pre-requisite information for clients looking to make a debut in this industry, and facilitates them to formulate schemes while going for an investment/partnership in the US BioDefense industry.

【レポートの目次】

1. Analyst View
2. Research Methodology
3. BioDefense – An Introduction
4. Global BioDefense Industry
5. BioDefense Industry Market Outlook to 2022
5.1 Anthrax
5.2 Small Pox
5.3 Botulism
5.4 Radiation
6. Industry Drivers
6.1 Innovative Technology Advancing the BioDefense Industry
6.2 Government Initiatives Contributing to BioDefense Infrastructure
6.3 Research and Development Enhancing Drug Efficiency
7. Industry Roadblocks
7.1 Biological threat detection: A National Challenge
7.2 Stringent Norms: Barriers to Clinical Testing
8. Regulatory Framework
9. Competitive Landscape
9.1 PharmAthene, Inc.
9.1.1 Business Description
9.1.2 Financial Overview
9.1.3 Recent Developments
9.2 Emergent BioSolutions
9.2.1 Business Description
9.2.2 Financial Overview
9.2.3 Recent Developments
9.3 Dynavax Technologies Corporation
9.3.1 Business Description
9.3.2 Financial Overview
9.3.3 Recent Developments
9.4 SIGA Technologies, Inc.
9.4.1 Business Description
9.4.2 Financial Overview
9.4.3 Recent Developments
9.5 Alnylam Pharmaceuticals, Inc.
9.5.1 Business Description
9.5.2 Financial Overview
9.5.3 Recent Developments
9.6 Cleveland Biolabs, Inc.
9.6.1 Business Description
9.6.2 Financial Overview
9.6.3 Recent Developments

List of Figures:

Figure 4-1: Share of US BioDefense Market, 2016
Figure 5-1: BioDefense Market (Billion US$), 2015-2022
Figure 5-2: BioDefense market by product (%), 2016
Figure 5-3: Anthrax BioDefense Market (Billion US$), 2015-2022
Figure 5-4: Small Pox BioDefense Market (Billion US$), 2015-2022
Figure 5-5: Botulism BioDefense Market (Billion US$), 2015-2022
Figure 5-6: Radiation BioDefense Market (Billion US$), 2015-2022

List of Tables

Table 3-1: Biological Weapons, by Type
Table 12-1: PharmAthene, Inc. – Key Financials (Million US$), 2013-2015
Table 12-2: Emergent Biosolutions – Key Financials (Million US$), 2013-2015
Table 12-3: Dynavax Technologies – Key Financials (Million US$), 2013-2015
Table 12-4: Siga Technologies – Key Financials (Million US$), 2013-2015
Table 12-5: Alnylam Pharmaceuticals, Inc. – Key Financials (Million US$), 2013-2015
Table 12-6: Cleveland Biolabs, Inc. – Key Financials (Million US$), 2013-2015



【レポートのキーワード】

生物テロ防御

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 生物テロ防御のアメリカ市場見通し2022(US Biodefense Market Outlook 2022)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆